- Global Pharma News & Resources

ifa systems confirms the very good year 2019

DGAP-News: ifa systems AG / Key word(s): Annual Results
28.04.2020 / 07:59
The issuer is solely responsible for the content of this announcement.

  • 2019 Annual Report published: preliminary figures confirmed
  • Revenues at € 9.7 million and EBITDA at € 3.9 million due to special effects at the upper end of the raised 2019 budget
  • Sales decline expected for 2020 due to corona, high recurring revenues provide stability

ifa systems AG, listed specialist for health IT applications in ophthalmology, today published its 2019 Annual Report and confirmed the preliminary figures announced on March 6, 2020. Revenue in fiscal year 2019 rose to € 9.7 million (previous year: € 6.6 million), boosted by special effects. At € 3.9 million, the operating result (EBITDA) tripled and EBIT reached € 1.2 million (previous year: € 0.1 million). The operating cash flow also developed positively and amounted to € 3.4 million. Financial liabilities were halved to € 3.0 million. "Our team delivered a great performance in 2019. We were able to strengthen many areas and put the company back on a successful footing," says Jörg Polis, CEO of ifa systems AG, about the 2019 results.

Fiscal year 2020

As a consequence of Covid-19, the global economy has been declining in recent weeks and health system players are focusing on managing the pandemic. "For our customers, the doctors in private practice as well as hospitals, priorities have changed, investments and projects are being postponed or are still awaiting decisions," says Jörg Polis. The Management Board therefore also expects ifa systems AG's sales and earnings performance in fiscal year 2020 to be affected." However, the large installed base and the high proportion of recurring revenues make the ifa Group more resistant to temporary fluctuations in demand," says Polis.

The Management Board remains optimistic about the medium and long-term prospects. The infection control measures in the context of the Corona pandemic are accelerating the use and acceptance of digital solutions that enable processes without physical contact between the parties involved. Management believes that these changes are sustainable and that the ifa Group will benefit from them in the medium term.


Annual Shareholder Meeting September 25, 2020 (expected)


Statements in this Corporate News that relate to future developments are based on our careful assessment of future events. The actual results of the company may differ considerably from the planned results, as they depend on a variety of market and economic factors, some of which are beyond the company's control.


The 2019 Annual Report is available for downloading at version only).

Contact for enquiries:
ifa systems AG
Augustinusstr. 11b
50226 Frechen
+49 2234 933 670

The Company:

With over 30 years of experience, ifa systems AG is one of the world's leading providers of software solutions in ophthalmology. The focus of the company's activities is on the development of an electronic patient record (EPA) tailored to the needs of ophthalmology. ifa's EPA, in which all details of examinations and treatments are documented and managed, can be flexibly used in specialist practices and eye centers as well as in specialized departments of hospitals. In addition, the range of products also includes supplementary software products for linking up ophthalmological diagnostic devices to a network. With its innovative product portfolio, ifa makes a decisive contribution to ensuring the optimal treatment of patients and supports the simplification of procedures for doctors and medical staff. With the products and solutions of ifa systems AG, people in more than 20 countries worldwide work at more than 15,000 workplaces, managing more than 200,000 clinical patient cases every day. According to experts, this niche market will grow to a volume of over 6.2 billion US dollars by 2020. ifa systems AG is listed on the Open Market of the Frankfurt Stock Exchange with ISIN DE 007830788. NEXUS AG holds more than 50% of the shares and is also listed on the stock exchange (ISIN DE0005220909).

Key figures as of December 31, 2019
ifa systems Group, acc. to IFRS

in EUR '000, if not stated otherwise 2015 2016 2017 2018 2019
Revenue 8,267 8,864 8,553 6,611 9,674
own development work capitalized 2,395 1,596 824 522 491
Total performance 11,676 11,893 9,592 7,930 10,605
EBITDA 3,414 1,030 -2,942 1,266 3,901
EBITDA margin (%)
in relation to total performance
25.2% 8.7% n.a. 16.0% 36.8%
EBIT 2,686 -2,216 -7,797 106 1,212
EBIT margin (%)
in relation to total performance
23.0% -18.6% n.a. 1.3% 11.4%
Consolidated net income / loss 2,062 -2,224 -9,291 740 1,202
Earnings per share (EUR) 0.75 -0.81 -3.38 0.27 0.44
Operating cash flow 1,708 1,222 544 -70 3,366
Free cash flow -1,108 -474 -296 -606 2,840
Total 26,446 22,965 20,740 18,588 16,444
Shareholders' equity 20,271 15,806 8,267 7,612 8,775
Equity ratio (%) 76.7% 68.8% 39.8% 41.0% 53.4%
Employees (average) 87 91 73 59 57
Performance per employee 134 131 131 134 170
Number of shares ('000) 2,750 2,750 2,750 2,750 2,750

28.04.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

Language: English
Company: ifa systems AG
Augustinusstraße 11 b
50226 Frechen
Phone: +49 (0)2234 93367-0
Fax: +49 (0)2234 93367-30
ISIN: DE0007830788
WKN: 783078
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1031181

End of News DGAP News Service

Editor Details

Last Updated: 28-Apr-2020